Cooke & Bieler LP Acquires 195,150 Shares of Teleflex Incorporated (NYSE:TFX)

Cooke & Bieler LP boosted its holdings in Teleflex Incorporated (NYSE:TFX) by 22.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,078,557 shares of the medical technology company’s stock after acquiring an additional 195,150 shares during the period. Teleflex accounts for 1.9% of Cooke & Bieler LP’s holdings, making the stock its 16th biggest position. Cooke & Bieler LP’s holdings in Teleflex were worth $191,962,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. Avior Wealth Management LLC raised its stake in Teleflex by 190.6% in the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock valued at $38,000 after acquiring an additional 101 shares during the period. Ashton Thomas Securities LLC acquired a new position in Teleflex in the 3rd quarter valued at $40,000. True Wealth Design LLC grew its holdings in Teleflex by 16,600.0% in the 3rd quarter. True Wealth Design LLC now owns 167 shares of the medical technology company’s stock valued at $41,000 after buying an additional 166 shares in the last quarter. Banque Cantonale Vaudoise grew its holdings in Teleflex by 184.8% in the 3rd quarter. Banque Cantonale Vaudoise now owns 225 shares of the medical technology company’s stock valued at $56,000 after buying an additional 146 shares in the last quarter. Finally, IFP Advisors Inc grew its holdings in Teleflex by 238.5% in the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company’s stock valued at $55,000 after buying an additional 217 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

Wall Street Analyst Weigh In

TFX has been the topic of a number of research reports. Royal Bank of Canada lowered Teleflex from an “outperform” rating to a “sector perform” rating and decreased their price objective for the company from $220.00 to $155.00 in a report on Friday, February 28th. Raymond James lowered Teleflex from an “outperform” rating to a “market perform” rating in a report on Friday, February 28th. Bank of America lowered Teleflex from a “neutral” rating to an “underperform” rating and decreased their price objective for the company from $235.00 to $140.00 in a report on Tuesday, March 4th. Morgan Stanley reduced their target price on Teleflex from $275.00 to $191.00 and set an “overweight” rating on the stock in a report on Wednesday, March 5th. Finally, Truist Financial reduced their target price on Teleflex from $200.00 to $149.00 and set a “hold” rating on the stock in a report on Monday, March 3rd. One analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat, Teleflex currently has a consensus rating of “Hold” and an average target price of $182.63.

Teleflex Stock Performance

NYSE:TFX opened at $138.40 on Tuesday. The stock’s 50-day simple moving average is $170.36 and its 200 day simple moving average is $200.33. The firm has a market capitalization of $6.42 billion, a PE ratio of 27.51, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a twelve month low of $128.55 and a twelve month high of $249.90.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating the consensus estimate of $3.86 by $0.03. The business had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. On average, analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 17th. Investors of record on Friday, March 7th will be paid a $0.34 dividend. This represents a $1.36 annualized dividend and a yield of 0.98%. The ex-dividend date of this dividend is Friday, March 7th. Teleflex’s dividend payout ratio (DPR) is presently 95.77%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.